Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

Medicine & Life Sciences

• Mendelian Randomization Analysis 100%
• Neoplasms 20%
• National Cancer Institute (U.S.) 10%
• National Institutes of Health (U.S.) 9%
• Epidemiologic Studies 7%
• Interleukin Receptors 6%
• Macrophage Migration-Inhibitory Factors 6%
• Adrenomedullin 6%
• Interleukin-23 5%
• Triple Negative Breast Neoplasms 5%
• Interleukin-1 Receptors 5%
• Organized Financing 5%
• Prothrombin 5%
• European Union 5%
• Basal Cell Carcinoma 5%
• Finland 4%
• Genome-Wide Association Study 4%
• Biomedical Research 4%
• Urinary Bladder Neoplasms 4%
• Pancreatic Neoplasms 4%
• Arthritis 3%
• Meta-Analysis 3%
• Joints 3%
• Genome 3%
• Breast Neoplasms 2%
• Inflammation 2%

Chemistry

• Marker 54%
• Prothrombin 8%